The Report Store is a repository of research reports that are available for online purchase. Each provides an in-depth analysis of a single product or class of products in development within the pharmaceutical, biotechnology, device or diagnostics industries. The goal is to provide actionable insights that enable smart investment decisions around emerging product opportunities. Typically, the reports address:
The scientific and medical rationale for use in the target indication
The strength of available human efficacy and safety data, including the probability of late-phase trial success
Regulatory (eg, FDA) concerns and their likely impact on approval and labeling
Commercial opportunities, including an assessment of the competitive landscape and reimbursement issues.
This report reviews the underlying rationale for NK-1 therapy, the available phase II rolapitant data and the probability of phase III success, the history of relevant precedents and the probability of regulatory success, and importantly, rolapitant’s ability to compete against Emend in the marketplace. Learn More
This report discusses the likelihood of Ravicti's approval in UCDs, strength of clinical evidence in HE, potential regulatory and marketing issues, and commercial prospects for Hyperion’s liver franchise.
This report explores the probability of a favorable outcome for the CHAMPION-PHOENIX phase III trial, the likelihood of FDA approval, and the market opportunity for this novel P2Y12 receptor inhibitor. Learn More